Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis
Authors:
Open Access
- 1 November 2019
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 19 (11) , 1246-1254
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 yearsVaccine, 2012
- Age‐Dependent Differences in IgG Isotype and Avidity Induced by Measles Vaccine Received during the First Year of LifeThe Journal of Infectious Diseases, 2007
- Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII® at 15 months of age and antibody levels at 27 months of ageVaccine, 2005
- Humoral and Cell‐Mediated Immune Responses to an Early 2‐Dose Measles Vaccination Regimen in the United StatesThe Journal of Infectious Diseases, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Immune Responses to Measles and Mumps Vaccination of Infants at 6, 9, and 12 MonthsThe Journal of Infectious Diseases, 2001
- Optimal age for vaccination against measles in the State of São Paulo, Brazil, taking into account the mother’s serostatusVaccine, 2001
- The effect of dose and strain of live attenuated measles vaccines on serological responses in young infantsBiologicals, 1995
- Measles vaccination of infants in a well-vaccinated populationThe Pediatric Infectious Disease Journal, 1995
- The Optimal Age for Vaccination Against Measles in an Asiatic City, Taipei, Taiwan: Reduction of Vaccine Induced Titre by Residual Transpiacental AntibodyInternational Journal of Epidemiology, 1983